EP 0879279 A4 2000-07-12 - DIABETES THERAPY

Title (en)

Title (de)

Title (fr)

Publication

Application

Priority

GB 9603847 A 19960223

US 9701978 W 19970206

US 1211196 P 19960206

Abstract (en)

[origin: WO9729180A1] The invention provides a gene therapy method for delivering safe and effective, long-term amounts of GLP-1(7-37)-based proteins useful for treating Type I and Type II diabetes. The invention eliminates the need for subcutaneous injections and is able to provide tight glucose control.